MedTrace Logo

Carnitine and Liver Mitochondria Fatty Acid Processing

NCT03193125 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2022-09-29

No results posted yet for this study

Summary

This double-blind, placebo-controlled randomized trial will assess whether 14 days of oral carnitine supplementation modifies mitochondrial fatty acid processing in healthy young adults.

Conditions

Interventions

DIETARY_SUPPLEMENT

L-Carnitine

500 mg tablets of L-Carnitine taken 3 times daily before meals.

DIETARY_SUPPLEMENT

Placebo

500 mg tablets of L-Carnitine taken 3 times daily before meals.

Sponsors & Collaborators

  • University of Tennessee

    collaborator OTHER

  • Touro University

    collaborator OTHER

  • Pennington Biomedical Research Center

    lead OTHER

Principal Investigators

  • Owen Carmichael, Ph.D. · Pennington Biomedical Research Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-15
Primary Completion
2018-05-11
Completion
2018-05-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03193125 on ClinicalTrials.gov